BNRPF:OTC-Solon Eiendom ASA (USD)

COMMON STOCK | Real Estate-Development | OTC

Last Closing Price

USD 2.48

Change

0.00 (0.00)%

Market Cap

USD 0.31B

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Solon Eiendom ASA acquires, develops, and sells residential real estate properties in Norway. The company was formerly known as Bionor Pharma ASA and changed its name to Solon Eiendom ASA. The company was founded in 2006 and is headquartered in Oslo, Norway.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-09 )

Largest Industry Peers for Real Estate-Development

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CHVKY China Vanke Co., Ltd

N/A

USD54.26B 6.10 0.53
CHVKF China Vanke Co., Ltd

N/A

USD50.26B 7.61 0.68
SUHJY Sun Hung Kai Properties Limite..

+0.19 (+1.25%)

USD44.09B 15.76 1.72
SUHJF Sun Hung Kai Properties Limite..

N/A

USD43.68B 15.24 1.72
LGFRY Longfor Group Holdings Limited

-1.33 (-2.02%)

USD40.04B 12.95 1.17
LNGPF Longfor Group Holdings Limited

N/A

USD39.36B 11.42 1.17
CRBJY China Resources Land Limited

N/A

USD34.02B 7.18 0.56
CRBJF China Resources Land Limited

N/A

USD33.31B 7.39 0.56
CAOVY China Overseas Land & Investme..

-0.74 (-5.51%)

USD31.16B 4.43 0.63
CTRYF Country Garden Holdings Compan..

N/A

USD28.07B 5.23 0.60

ETFs Containing BNRPF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Real Estate-Development)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.52% 80% B- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.52% 79% C+ 65% D
Trailing 12 Months  
Capital Gain -15.93% 25% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.93% 21% F 12% F
Trailing 5 Years  
Capital Gain 3,000.00% 98% A+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 3,000.00% 98% A+ 95% A
Average Annual (5 Year Horizon)  
Capital Gain N/A 100% A+ 100% A+
Dividend Return 32,673.28% 100% A+ 99% A+
Total Return N/A 100% A+ 100% A+
Risk Return Profile  
Volatility (Standard Deviation) N/A 1% F N/A N/A
Risk Adjusted Return 44.41% 77% C+ 76% C
Market Capitalization 0.31B 26% F 60% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Real Estate-Development)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.34 26% F 47% F
Price/Book Ratio 1.39 11% F 57% F
Price / Cash Flow Ratio -1.94 73% C 67% D+
EV/EBITDA 24.65 16% F 17% F
Management Effectiveness  
Return on Equity 7.60% 59% F 66% D
Return on Invested Capital 0.91% 33% F 50% F
Return on Assets 1.51% 43% F 64% D
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.50 77% C+ 67% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.